hotspot -WSS

hotspot

author：comprehensive 2025-09-14 18:24:43 - browse：4

Verve Therapeutics CEO Sekar Kathiresan Verve

SAN FRANCISCO — The promise of genome editing has given rise to potentially curative medicines for rare, life-threatening diseases that generally affect small numbers of patients. But since Verve Therapeutics was founded in 2018, it’s had a wider aperture: using the molecular tools of genome editing to go after the most common cause of death in the world.

The plan, according to Verve CEO Sekar Kathiresan, is to edit out heart attacks for the millions of people at risk for severe cardiovascular disease. It’s a goal that’s more than a little audacious. There’s just one approved genome editing medicine, a treatment for sickle cell disease, and it only passed Food and Drug Administration review last month. Base editing, the CRISPR successor Verve uses to conduct its molecular surgery, is only a few years old.

“When we started, there were so many things that we were kind of going against the grain on,” Kathiresan told STAT at the J.P. Morgan Healthcare Conference in San Francisco this week. “In 2018, it was all about platforms, not about specific diseases and products, or taking this kind of idea for a large indication as opposed to cancer or rare disease. But we’ve always been motivated by a deep conviction in one simple research insight, which is that if your blood cholesterol is really low, lifelong, it is very hard to get a heart attack.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： AstraZeneca chief proposes a novel edit to the drug pricing bill

explore

Wikipedia

hotspot

WSS

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

A new House health package & hospitals’ new site

Asahi Kasei to buy Calliditas, picking up kidney disease drug

'Make People Better': The CRISPR babies story you probably don't know

Humana sues Biden admin over Medicare Advantage audit rule

Crinetics acromegaly drug succeeds in late

explore

hotspot

entertainment

How to save PrEP access — and even expand it

Medicaid rebukes states for mistakenly disenrolling children

New air purifier tech could be key to improving indoor air quality

Medical students need to learn the potent medicine of empathy

Medicare proposal to cover medical devices draws a mixed reaction

J&J reports mixed data on next

23andMe had bad news about my health. I wish a person had delivered it

Decentralized clinical trials need collaboration to achieve wider use

Duchenne breakthrough therapy leaves behind pioneering families

Illumina names Agilent executive as new CEO

knowledge

A rare thyroid diagnosis led to unexpected, all

The world needs the new pandemic treaty

The (many) problems with a new study criticizing cancer screening

The 10 drugs up first for Medicare price negotiation

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

explore

Wikipedia

hotspot

leisure time